65,437 trials
HIV · Endothelial Dysfunction · Inflammation
Primary: Change in Flow Mediated Dilation (FMD) of the Brachial Artery Measured by Ultrasound Over 13 Weeks — 0.99; -0.07 % change from baseline — p=<0.05
Fever · Brain Hemorrhage
Primary: Core Temperature as Measured With an Approved Device (Urinary Catheter) in Place for Usual Clinical Care — 100.8; 100.3; 99.9; 99.5 degrees F
Healthy Volunteers
Primary: Gemfibrozil Area Under the Concentration vs. Time Curve (AUC) — 104; 62 ng*hr/mL — p=<0.0001
Stable Coronary Artery Disease
Primary: Inhibition of Platelet Aggregation(IPA) Final Extent at 2 Hours Post Dose on Week 4 in Japanese Patients — 64.5; 73.0; 38.9 percentage inhibition
Marijuana Abuse · Attention Deficit Disorder With Hyperactivity
Primary: Estimated Week 12 Self-reported Use — 2.17; 1.84 Times per day
Postoperative Pain
Primary: Cmax (the Maximum Observed Plasma Concentration) — 1153.9; 1625.3 ng/mL
Surgery
Primary: Surgery Site CFU Density — 3.08; 1.73 CFU/m3
Moderate to Severe Psoriasis
Primary: Percentage of Participants Achieving a 75 Percent (%) Improvement in Psoriasis Area and Severity Index (PASI 75) Score at Week 24 — 52.38; 57.89; 22.22 percentage of…
Uveitis
Primary: Cumulative Endpoint — 21 participants
Opioid-Induced Hyperalgesia
Primary: Change in Pain Threshold Time From Baseline to Week 5 — 2.95; -3.49 seconds
Bipolar Disorder · Mania
Primary: Change in Bipolar Symptoms as Measured by Reduction in Young-Mania Rating Scale (Y-MRS) Total Score — -14.5 Units on a scale
Sepsis · Trauma
Primary: Length of Stay — 9.5; 7.3 days
Essential Hypertension
Primary: Change in Seated Diastolic Blood Pressure (SeDBP). — -22.5; -22.5; -23.0; -23.9 mm HG — p=0.0071
Early Breast Cancer
Primary: Number of Participants With New Events of Arthralgia — 37 Participants
Bipolar Disorder · Mania
Primary: Change of Mania Symptoms Assessed by Young Mania Rating Scale (YMRS) — -14.9 Units on a scale